Could a cheap arthritis drug replace harmful steroids for transplant patients?
Disease control
Terminated
This study tested leflunomide, a drug used for rheumatoid arthritis, as a first treatment for musculoskeletal graft-versus-host disease (GVHD) — a condition where donor cells attack a patient's joints and muscles after a stem cell transplant. The goal was to see if leflunomide co…
Phase: PHASE2 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated May 17, 2026 03:14 UTC